EquityFlowCompanies › Xyall

Xyall

Healthtech · Eindhoven, NL

Dutch medtech automating tissue dissection for molecular pathology diagnostics.

Funding history

DateRoundAmount
Jun 2022Series B
Eindhoven molecular-pathology medtech Xyall raised a 6M euro Series B to commercialise its Tissector tissue-dissection systems.
$6M

Similar companies in Healthtech

Explore funding flow on EquityFlow →